Because our pilot experiment using plasma from lung cancer patients did not allow detection of tumour markers by WB, to compare the sensitivity of immunocapture we used plasma from patients with other epithelial tumours in which high expression of EpCAM has been reported in EVs [36, 37]. The gene discussed is EPCAM; the disease is neoplasm.